Physiotherapy, Nutritional Supplement and Anabolic Steroids in Rehabilitation of Patients With Hip Fracture.
Completed
Morten Tange Kristensen PT, PhD
Phase 2
2018-09-03
This pilot trial investigates the preliminary effect and safety of a 12 week multi-modal
intervention initiated during admission in the acute ward after hip fracture surgery. The
intervention under investigation is a combination therapy consisting of physiotherapy,
protein-rich nutritional supplement and nandrolone decanoate (Deca-Durabolin) supplement. The
investigators expect the combination therapy to be a preliminary effective and safe treatment
in elderly patients with hip fracture and that this combination therapy intervention program
is more efficacious in improving muscle strength, and physical function 14 weeks after hip
fracture surgery, compared to physiotherapy, protein-rich nutritional supplement plus
placebo.
The serious injury causes a complex acute response of the organism to the injury in affected
patients, which is manifested in the neuroendocrine, immune and metabolic areas, with an
often persisting catabolic state, with a subsequent negative impact upon bone metabolism.
By a timely administration of the D3 vitamin and an anabolic, we attempt to achieve an
earlier activation of the anabolic phase of patient resuscitation after serious trauma
regarding the monitoring of laboratory values of bone metabolism.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
